Thames V.2 Dp67 Regulatory News (D467)

3 Jun 2021 15:42

Downing FOUR VCT plc (the “Company”)LEI: 21380035MV1VRYEXPR953 June 2021Portfolio Update 

The Directors of the Company are pleased to report that Generalist and Healthcare Share portfolio company, Arecor Therapeutics (“Arecor”), has today had its ordinary shares admitted to trading on AIM. The admission follows a successful £20.0 million placing of new shares at a price of 226 pence per ordinary share (the “placing price”).

Based on the placing price, the values of the Company’s Generalist and Healthcare Share pools’ holdings in Arecor have increased by approximately 0.9p per Generalist Share and 8.0p per Healthcare Share. This is equivalent to increases of 1.3% and 11.4% in the unaudited NAVs of the Generalist and Healthcare Share pools respectively, as at 28 February 2021 (being the most recent NAVs announced by the Company).

Enquiries:Grant WhitehouseDowning LLPCompany Secretary020 7630 4333